DE3782434D1 - Kovalent gebundene mittel mit kohlenstoffionen-gruppen. - Google Patents
Kovalent gebundene mittel mit kohlenstoffionen-gruppen.Info
- Publication number
- DE3782434D1 DE3782434D1 DE8787906338T DE3782434T DE3782434D1 DE 3782434 D1 DE3782434 D1 DE 3782434D1 DE 8787906338 T DE8787906338 T DE 8787906338T DE 3782434 T DE3782434 T DE 3782434T DE 3782434 D1 DE3782434 D1 DE 3782434D1
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- active agents
- base groups
- covalently bonded
- covalent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/912,352 US4842868A (en) | 1986-09-26 | 1986-09-26 | Covalently bonded active agents with carbonium ion base groups |
PCT/US1987/002228 WO1988002252A1 (en) | 1986-09-26 | 1987-09-03 | Covalently bonded active agents with carbonium ion base groups |
CA000574727A CA1321577C (en) | 1986-09-26 | 1988-08-15 | Covalently bonded active agents with carbonium ion base groups |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3782434D1 true DE3782434D1 (de) | 1992-12-03 |
DE3782434T2 DE3782434T2 (de) | 1993-03-11 |
Family
ID=25672052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8787906338T Expired - Fee Related DE3782434T2 (de) | 1986-09-26 | 1987-09-03 | Kovalent gebundene mittel mit kohlenstoffionen-gruppen. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4842868A (de) |
EP (1) | EP0321499B1 (de) |
AT (1) | ATE81772T1 (de) |
AU (1) | AU614498B2 (de) |
CA (1) | CA1321577C (de) |
DE (1) | DE3782434T2 (de) |
WO (1) | WO1988002252A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5456904A (en) * | 1993-06-28 | 1995-10-10 | The Procter & Gamble Company | Photoprotection compositions comprising certain chelating agents |
US20050152950A1 (en) * | 1995-11-13 | 2005-07-14 | Saffran Bruce N. | Method and apparatus for macromolecular delivery using a coated membrane |
CA2497195C (en) * | 2001-12-14 | 2014-07-08 | The University Of Wyoming | Methods and compositions for controlled release of drugs |
US9050393B2 (en) | 2005-02-08 | 2015-06-09 | Bruce N. Saffran | Medical devices and methods for modulation of physiology using device-based surface chemistry |
GB0908781D0 (en) | 2009-05-21 | 2009-07-01 | Cadbury Uk Ltd | Confectionery product |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4304767A (en) * | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
US4532335A (en) * | 1983-03-07 | 1985-07-30 | Sri International | Preparation of ketene acetals by rearrangement of allyl and substituted allyl acetals |
US4610870A (en) * | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
GB8430252D0 (en) * | 1984-11-30 | 1985-01-09 | Beecham Group Plc | Compounds |
NZ217821A (en) * | 1985-10-10 | 1989-07-27 | Biotech Australia Pty Ltd | Oral delivery system; complex of active agent and vitamin b12 or analogue thereof |
-
1986
- 1986-09-26 US US06/912,352 patent/US4842868A/en not_active Expired - Lifetime
-
1987
- 1987-09-03 AU AU80325/87A patent/AU614498B2/en not_active Ceased
- 1987-09-03 AT AT87906338T patent/ATE81772T1/de not_active IP Right Cessation
- 1987-09-03 DE DE8787906338T patent/DE3782434T2/de not_active Expired - Fee Related
- 1987-09-03 EP EP87906338A patent/EP0321499B1/de not_active Expired - Lifetime
- 1987-09-03 WO PCT/US1987/002228 patent/WO1988002252A1/en active IP Right Grant
-
1988
- 1988-08-15 CA CA000574727A patent/CA1321577C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE81772T1 (de) | 1992-11-15 |
WO1988002252A1 (en) | 1988-04-07 |
AU614498B2 (en) | 1991-09-05 |
US4842868A (en) | 1989-06-27 |
EP0321499A4 (de) | 1990-04-10 |
EP0321499A1 (de) | 1989-06-28 |
EP0321499B1 (de) | 1992-10-28 |
AU8032587A (en) | 1988-04-21 |
DE3782434T2 (de) | 1993-03-11 |
CA1321577C (en) | 1993-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5091171B2 (en) | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use | |
MX9206034A (es) | Sistema para el control de plagas. | |
ATE133534T1 (de) | Antimikrobizides gemisch | |
ES2171498T3 (es) | Composicion farmaceutica solida que comprende un excipiente capaz de juntarse con el agua. | |
DK0621038T3 (da) | Farmaceutiske præparater indeholdende silikatpolymere | |
CA2130450A1 (en) | Insect Repellent | |
BR9004590A (pt) | Composicao inseticida e/ou acaricida,processo para controlar insetos e/ou acaros e processos para produzir uma formulacao,um aerossol e um concentrado emulsionavel para controlar insetos e/ou acaros | |
DE3782434T2 (de) | Kovalent gebundene mittel mit kohlenstoffionen-gruppen. | |
FR2490491B1 (fr) | Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application | |
ES554822A0 (es) | Procedimiento para el desarrollo de treponema hyodysenteriae en un medio nutriente adecuado | |
JPS5640605A (en) | Cosmetic | |
FR2618980B1 (fr) | Dispersion aqueuse ou hydroalcoolique stable a base de derives d'oxynil et composition herbicide en comportant | |
BE847024A (fr) | Ester o,o-diethyle et 0-(n-methoxy-2-nitrobenzimidoyle) d'acide thionophorique, son procede de preparation et son application comme insecticides et acaricide | |
ES2123301T3 (es) | Emulsiones polimericas acuosas | |
DE3381583D1 (de) | Konditionierungsmittel fuer fettiges haar. | |
FR2657010B1 (fr) | Composition pharmaceutique sous forme de suspension aqueuse stable a base de sucrafalte et d'une substance anti-acide ainsi que son procede de preparation. | |
KR860001589A (ko) | 용제형태의 손톱용 에나멜 조성물 | |
FR2643637B1 (fr) | Complexe d'ion calcium avec au moins un acide gras insature, agent biomediateur comprenant un tel complexe, composition pharmaceutique l'incorporant et extraits de plantes ou d'organes d'animaux en contenant | |
JPS5548386A (en) | Novel mocroorganism and fecal matter deodorant | |
ES2060955T3 (es) | Composiciones farmaceuticas que tienen velocidad diferencial de liberacion de farmacos. | |
KR890004995A (ko) | 안정된 입상농약비료 | |
CS274548B2 (en) | Method of water-absorbing resin's surface treatment | |
SE9003700D0 (sv) | Insekticid komposition | |
FR2648458B1 (fr) | Acide diallyloxyacetique et ses sels d'addition basiques, leur procede de preparation et leur application comme agent reticulant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |